Advances in spinal muscular atrophy therapeutics
V Parente, S Corti - Therapeutic advances in neurological …, 2018 - journals.sagepub.com
Spinal muscular atrophy (SMA) is a progressive, recessively inherited neuromuscular
disease, characterized by the degeneration of lower motor neurons in the spinal cord and …
disease, characterized by the degeneration of lower motor neurons in the spinal cord and …
Spinal muscular atrophy: the past, present, and future of diagnosis and treatment
H Nishio, ETE Niba, T Saito, K Okamoto… - International Journal of …, 2023 - mdpi.com
Spinal muscular atrophy (SMA) is a lower motor neuron disease with autosomal recessive
inheritance. The first cases of SMA were reported by Werdnig in 1891. Although the …
inheritance. The first cases of SMA were reported by Werdnig in 1891. Although the …
Spinal muscular atrophy: therapeutic strategies
D Castro, ST Iannaccone - Current treatment options in neurology, 2014 - Springer
Opinion statement Spinal muscular atrophy is caused by mutations in the survival motor
neuron 1 (SMN1) gene, leading to the reduction of SMN protein. The loss of alpha motor …
neuron 1 (SMN1) gene, leading to the reduction of SMN protein. The loss of alpha motor …
Spinal muscular atrophy: recent advances and future prospects
S Nicole, CC Diaz, T Frugier… - Muscle & Nerve: Official …, 2002 - Wiley Online Library
Spinal muscular atrophies (SMA) are characterized by degeneration of lower motor neurons
associated with muscle paralysis and atrophy. Childhood SMA is a frequent recessive …
associated with muscle paralysis and atrophy. Childhood SMA is a frequent recessive …
Spinal muscular atrophy: overview of molecular diagnostic approaches
TW Prior, N Nagan - Current protocols in human genetics, 2016 - Wiley Online Library
Spinal muscular atrophy (SMA) is an autosomal recessive neurodegenerative disease and
the most common genetic cause of infant mortality, affecting∼ 1 in 10,000 live births. The …
the most common genetic cause of infant mortality, affecting∼ 1 in 10,000 live births. The …
New therapeutic approaches to spinal muscular atrophy
A Lewelt, TM Newcomb, KJ Swoboda - Current neurology and …, 2012 - Springer
Bench to bedside progress has been widely anticipated for a growing number of
neurodegenerative disorders. Of these, spinal muscular atrophy (SMA) is perhaps the best …
neurodegenerative disorders. Of these, spinal muscular atrophy (SMA) is perhaps the best …
Spinal muscular atrophy
M Oskoui, P Kaufmann - Neurotherapeutics, 2008 - Springer
Spinal muscular atrophy (SMA) is a potentially devastating and lethal neuromuscular
disease frequently manifesting in infancy and childhood. The discovery of the underlying …
disease frequently manifesting in infancy and childhood. The discovery of the underlying …
Spinal muscular atrophy: new findings for an old pathology
D Bottai, R Adami - Brain pathology, 2013 - Wiley Online Library
Understanding the events that are responsible for a disease is mandatory for setting up a
therapeutic strategy. Although spinal muscular atrophy (SMA) is considered a rare …
therapeutic strategy. Although spinal muscular atrophy (SMA) is considered a rare …
Systemic nature of spinal muscular atrophy revealed by studying insurance claims
SL Lipnick, DM Agniel, R Aggarwal, NR Makhortova… - PLoS …, 2019 - journals.plos.org
Objective We investigated the presence of non-neuromuscular phenotypes in patients
affected by Spinal Muscular Atrophy (SMA), a disorder caused by a mutation in the Survival …
affected by Spinal Muscular Atrophy (SMA), a disorder caused by a mutation in the Survival …
[HTML][HTML] Opening the window: the case for carrier and perinatal screening for spinal muscular atrophy
JK Burns, R Kothary, RJ Parks - Neuromuscular disorders, 2016 - Elsevier
Spinal muscular atrophy (SMA) is the most common genetically inherited neurodegenerative
disease that leads to infant mortality worldwide. SMA is caused by genetic deletion or …
disease that leads to infant mortality worldwide. SMA is caused by genetic deletion or …